HyperRho-D (Rho(D) Immune Globulin-Human) (SD Viral Inactivated) Warnings

Bayrho-D (Rho(D) Immune Globulin-Human) (SD Viral Inactivated) is made from human plasma. Products made from human plasma may contain infectious agents eg, viruses, that can cause disease. The risk that such products will transmit an infectious agent has been reduced by screening plasma donors for prior exposure to certain viruses, by testing for the presence of certain current virus infections, and by inactivating and/or removing certain viruses. Despite these measures, such products can still potentially transmit disease. There is also the possibility that unknown infectious agents may be present in such products. Individuals who receive infusions of blood or plasma products may develop signs and/or symptoms of some viral infections, particularly hepatitis C. All infections thought by a physician possibly to have been transmitted by Bayrho-D (Rho(D) Immune Globulin-Human) (SD Viral Inactivated) should be reported by the physician or other healthcare provider to Bayer Corporation.
The physician should discuss the risks and benefits of Bayrho-D (Rho(D) Immune Globulin-Human) (SD Viral Inactivated) with the patient before prescribing or administering it to the patient.
Never administer Bayrho-D (Rho(D) Immune Globulin-Human) (SD Viral Inactivated) IV. Inject only IM. Never administer to the neonate.
Rho(D) immune globulin (human) should be given with caution to patients with a history of prior systemic allergic reactions following the administration of human immunoglobulin preparations.
The attending physician who wishes to administer Rho(D) immune globulin (human) to persons with isolated immunoglobulin A (IgA) deficiency must weigh the benefits of immunisation against the potential risks of hypersensitivity reactions. Such persons have increased potential for developing antibodies to IgA and could have anaphylactic reactions to subsequent administration of blood products that contain IgA.
As with all preparations administered by the IM route, bleeding complications may be encountered in patients with thrombocytopenia or other bleeding disorders.